BIOSPAIN 2026

BIOSPAIN 2026

arrow_back View All Dates

09:30 CEST

Beyond Venture Capital Building Alternative Financing Pathways for Biotech Growth 4 Raúl Martín roomOscar Salazar • Jesús González Nieto-Márquez • Mercedes Storch • Olatz Azpiazu Aguirre • Manuel Ramos Biotech Act: Accelerating Biotech Scale-Up and Building Competitive Value Chains in Europe 1 Margarita Salas auditoriumIon Arocena • Ana María Bravo • Miguel Gómez-Pavón López • Kristin Schreiber The Clinical Future of Bioprinting: From biofabrication technologies to next-generation regenerative therapies 2 Dorotea Barnés roomBeatriz Olalde • Anthony Remazeilles • Begoña Ferrari • Francisco Miguel Sánchez Margallo • Jesús María Izco Zaratiegui • Luc Milbergue

10:15 CEST

Biomanufacturing at an Inflection Point: Technology Breakthroughs, Scale-Up Challenges and the Future of the CMO Model 3 Nicolás Achúcarro roomTom Manelius • Marcel de Matas • Natalia Serrano Morillas Regulating Intelligence: Bringing AI-Powered Medical Devices to the European Market under MDR and the AI Act 1 Margarita Salas auditoriumItziar Alkorta Idiakez • Oskar Berreteaga Castro • María Teresa Gómez Manzano • Talyta Carteano Translating Breakthroughs to Next‑Generation Therapies for ALS 2 Dorotea Barnés roomMaite Solas • Manuel Cuervas-Mons Cantón • Yosu Vara • Adolfo López de Munain • Ana Martínez Gil

11:30 CEST

Fishing in the Atlantic Marine Biotech Innovation Ecosystem: from potential to societal impact 3 Nicolás Achúcarro roomElisabete da Costa • Luís Costa • Tiago H. Silva • Marta Conde Sieira • Ibon Cancio From Platform to Patient: Scaling Biotech and Advanced Therapies Through Integrated CDMO Ecosystems 2 Dorotea Barnés roomAndreu Soldevilla • Natalia Elizalde • David Blanco • András Dinnyés The Role of Regional Ecosystems in Driving the Biotech Sector 1 Margarita Salas auditoriumCarlota Gómez de la Hoz • Daniel Álvarez • Zara Pons Vila • Idoia Muñoz Lizán • Robert Fabregat • Jesús Agüero González

12:15 CEST

Can Cooperative Models Transform the Future of Pharma and Healthcare? 1 Margarita Salas auditoriumRaúl Pérez • Manuel Sánchez-Lagarejo From Lab to Market: Financing Spain’s Deep-Tech Future through Innvierte & Tech Transfer and the EIC Accelerator 4 Raúl Martín roomÁngel Sánchez • Myriam Rouis • Moisés Martín Carretero • Marc Ramis Castellfort • Clara Campás From Science to Market: The Value of Engineering Across the Biotech Product Lifecycle 2 Dorotea Barnés roomJordi Gibert Amat New Approach Methodologies (NAMs): Accelerating Safer, Smarter and More Human-Relevant Innovation in Drug and Chemical Development 3 Nicolás Achúcarro roomCarmen Martín González • Natalia Sánchez • John Kendrick • Simón Perera del Rosario

14:30 CEST

Accelerating Oncology Innovation: Collaborative Models for Early Translation 2 Dorotea Barnés roomSofía Cabezudo • Laureano Simón • Arkaitz Carracedo • Eider Sánchez • Fernando Aguirre Advancing Transplant Innovation: Bridging Clinical Excellence with Smarter Drug Development 1 Margarita Salas auditoriumPedro Carrascal • Tabikh Ammar • Isabel Portero Unlocking Opportunities in precision fermentation for the food industry 3 Nicolás Achúcarro roomJose Luis Moreno Carboneros • Laura Pedrós Manzanares • Guadalupe Monserrat Alvarado Jasso • Ana Torrejón Cabello

15:15 CEST

Circularity at Scale: The 2030 Value Chain Challenge 3 Nicolás Achúcarro roomLara Valentín • Armando Menéndez Estrada • Loretxu García • David San Martín Errea Current innovation trends in therapeutic technologies and modalities: what is the potential of Spain to ride these waves? 2 Dorotea Barnés roomMontserrat Vendrell • Gloria González • Pilar Carrato • Robert Fabregat • Gurutz Linazasoro Substance Matters: From Microbiome Breakthroughs to EU Benchmarks 1 Margarita Salas auditoriumClaudio Hidalgo Cantabrana • María José Reyes • Dominika Misztela • Patricia del Río

16:00 CEST

One Health Diagnostics: Rapid Detection and Characterization of Multidrug Resistant Bacteria to Enable Next Generation Antimicrobials 1 Margarita Salas auditoriumRaquel Carnero • Juan José Infante Viñolo • Larraitz Añorga Gómez • Santos Merino • Bruno González-Zorn

16:30 CEST

MythBusters: The Realities of Biotech Capital 4 Raúl Martín roomAvencia Sánchez Mejías • Malgorzata Rogalska

16:45 CEST

From Biotechnology to Clinical Intelligence: How to Build Biotech Solutions Powered by Software and AI, Interoperable by Design in Europe. Practical case: use in histopathology for biomarker identification 1 Margarita Salas auditoriumCarmen Martín González • María Teresa Gómez Manzano • Valery Naranjo • Anna Rosés • Marta Montilla Rare Diseases at a Turning Point: From Gene Editing to Precision Medicines 2 Dorotea Barnés roomÓscar Millet • María Fernández Jiménez • Inmaculada Gilaberte Asin • Amalia Capilla